Viewing Study NCT02380235


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2026-02-22 @ 7:23 AM
Study NCT ID: NCT02380235
Status: UNKNOWN
Last Update Posted: 2017-06-16
First Post: 2015-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Growth Hormone Deficiency View
Keywords: